Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in October
September 30, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Sept. 30, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in September
September 07, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Sept. 07, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
July 26, 2021 07:05 ET | uniQure Inc.
~ Expanded gene therapy pipeline with four new research programs and announced acquisitionof Corlieve Therapeutics ~ ~ Presented positive 52-week data from HOPE-B pivotal study demonstrating...
Logo-uniQure-MS-Word_Orange.jpg
UPDATE -- uniQure to Participate in Multiple Upcoming Industry Conferences in June
June 02, 2021 10:31 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in June
June 02, 2021 07:34 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces First Quarter 2021 Financial Results and Highlights Recent Company Progress
May 10, 2021 07:05 ET | uniQure Inc.
~ 52-week follow-up data from HOPE-B pivotal study expected to be presented later this quarter ~ ~ Announced closing of the global commercialization and license agreement with CSL Behring for...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in May
May 03, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 03, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in April
April 01, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, April 01, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in March
February 26, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 26, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in February
February 01, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Feb. 01, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...